close
Trend Chart on Innovative Bioindustries – September 12th
Trend Chart On....

Trend Chart on Innovative Bioindustries – September 12th

FEATURE STORY
● 
The landscape of early clinical gene therapies outside oncology


BASIC SCIENCE
● 
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL

CLINICAL TRIALS/DATA
● 
ATL1102 for DMD commencement of European regulatory interactions
 UniQure stays a step ahead in hemophilia B

FINANCIAL DATA
● 
Passage Bio
Closes $110 Million Series B Financing 
 Achilles Therapeutics raises 100 M£ in oversubscribed series B financing
● 
Nkarta Therapeutics
raises $114 Million in Series B financing to advance multiple programs into clinical trial

M&A/AGREEMENTS
● 
Phio Pharmaceuticals announces research collaboration with Carisma Therapeutics to evaluate its self-delivering RNAi technology 
● 
Vertex
to acquire Semma Therapeutics with a goal of developing curative cell-based treatments for type 1 diabetes
● 
Sumitomo Dainippon
buys five Roivant companies for $3 Billion with option to buy six more

To read the full articles: Trend Chart on Innovative Bioindustries September 12th


COMMENTS ARE OFF THIS POST